Crinetics Pharmaceuticals (CRNX)

• Market cap: $5.05B
• 1 day: 0.02%
• 5 days: -3.18%
• 1 month: 11.17%
• 3 months: 16.37%
• 6 months: 64.71%
• Year to date: 13.95%
• 1 year: 31.19%
• 5 years: 271.34%
• 10 years: 117.26%
• Sector: Healthcare
• Industry: Biotechnology

About: Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Employees: 437